Annals of Thoracic Medicine Official publication of the Saudi Thoracic Society, affiliated to King Saud University
Search Ahead of print Current Issue Archives Instructions Subscribe e-Alerts Login 
Home Email this article link Print this article Bookmark this page Decrease font size Default font size Increase font size

    Article Cited by others


Predictors of mortality in interstitial lung disease patients without pulmonary hypertension

Alhamad Esam H, Cal Joseph G

Year : 2020| Volume: 15| Issue : 4 | Page no: 238-243

   This article has been cited by
1 Nintedanib and pirfenidone for idiopathic pulmonary fibrosis in King Abdulaziz Medical City, Riyadh: Real-life data
MohammedAyaz Khan, Nahed Sherbini, Sami Alyami, Abdullah Al-Harbi, Majed Al-Ghamdi, Suliman Alrajhi, Rajkumar Rajendram, Hamdan Al-Jahdali
Annals of Thoracic Medicine. 2023; 18(1): 45
[Pubmed]  [Google Scholar] [DOI]
2 Impacto de la rehabilitación pulmonar en pacientes con enfermedad pulmonar restrictiva
J. Betancourt-Peña, J.A. Rivera, L.M. Orozco, N. Torres-del Castillo, V. Benadives-Córdoba
Fisioterapia. 2022;
[Pubmed]  [Google Scholar] [DOI]
3 Physical activity, exercise capacity and mortality risk in people with interstitial lung disease: a systematic review and meta-analysis
Vânia Rocha, Cátia Paixão, Alda Marques
Journal of Science and Medicine in Sport. 2022;
[Pubmed]  [Google Scholar] [DOI]
4 Clinical characteristics and outcomes in patients with primary Sjogren's syndrome-associated interstitial lung disease
EsamH Alhamad, JosephG Cal, NuhaN Alrajhi, MuthurajanP Paramasivam, WaleedM Alharbi, Mohammed AlEssa, MohammedA Omair, AmmarC AlRikabi, AhmadA AlBoukai
Annals of Thoracic Medicine. 2021; 16(2): 156
[Pubmed]  [Google Scholar] [DOI]
5 Predictors of Mortality in Patients with Interstitial Lung Disease-Associated Pulmonary Hypertension
Esam H. Alhamad, Joseph G. Cal, Nuha N. Alrajhi, Waleed M. Alharbi
Journal of Clinical Medicine. 2020; 9(12): 3828
[Pubmed]  [Google Scholar] [DOI]


Read this article